Iktos
Pioneering AI and robotics in drug discovery
Iktos leverages generative AI and robotics to transform drug discovery. It integrates automated synthesis with design to accelerate treatment development.
| Best for | medicinal and computational chemistry teams |
| Website | iktos.ai |
Strengths and trade-offs
- The AI tool enables six times more parallel projects with the same number of chemists.
- Iktos reduces the timeline to under 24 months for drug discovery.
Appears in
Alternatives to Iktos
 Relay TherapeuticsPioneering motion-based drug design through protein dynamics | #1 in Best AI drug discovery platforms | 80.0 |
 SchrödingerOpening new worlds for molecular discovery | #2 in Best AI drug discovery platforms | 80.0 |
 Valo HealthThis is drug discovery re-imagined | #3 in Best AI drug discovery platforms | 80.0 |
 Insilico MedicineGenerative AI software for drug discovery | #5 in Best AI drug discovery platforms | 78.0 |
 TurbineA lab without limits for biopharma discovery | #6 in Best AI drug discovery platforms | 78.0 |
 AqemiaInventing new Drugs at scale with AI and physics | #7 in Best AI drug discovery platforms | 76.0 |
Questions about Iktos
Who is Iktos best for?
Iktos is best for medicinal and computational chemistry teams.
Where does Iktos rank?
Iktos is ranked #4 in Best AI drug discovery platforms (Lister Score 78.0).
What are the best alternatives to Iktos?
The closest alternatives on Lister are Relay Therapeutics (#1 in Best AI drug discovery platforms), Schrödinger (#2 in Best AI drug discovery platforms) and Valo Health (#3 in Best AI drug discovery platforms).
Is this your company?
Claim Iktos to suggest corrections to its listing (pricing, features, details) or ask about an enhanced profile. We review every claim before anything changes.